Skip to main content
AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
216.66
+2.37 (1.11%)
At close: Mar 10, 2025, 4:02 PM
217.33
+0.67 (0.31%)
After-hours: Mar 10, 2025, 4:18 PM EST

AbbVie Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Immunology
26.68B 26.34B 26.08B 25.92B 26.14B 27.11B 27.98B 28.37B
Immunology Growth
2.09% -2.83% -6.78% -8.64% -9.64% -2.30% 4.51% 10.47%
Neuroscience
9.00B 8.58B 8.26B 7.99B 7.72B 7.33B 6.96B 6.74B
Neuroscience Growth
16.61% 17.06% 18.70% 18.59% 18.21% 13.30% 9.36% 9.21%
Hematologic Oncology
6.56B 6.37B 6.20B 6.04B 5.92B 6.04B 6.18B 6.35B
Hematologic Oncology Growth
10.82% 5.57% 0.37% -4.81% -10.07% -11.47% -12.22% -11.86%
Aesthetics
5.18B 5.25B 5.25B 5.24B 5.29B 5.21B 5.27B 5.26B
Aesthetics Growth
-2.23% 0.75% -0.44% -0.30% -0.73% -4.46% -2.42% -3.79%
Other Products
3.65B 3.70B 3.79B 3.78B 3.81B 3.82B 3.85B 3.88B
Other Products Growth
-4.15% -3.14% -1.51% -2.50% -1.25% -11.01% -17.57% -23.74%
Eye Care
2.24B 2.18B 2.26B 2.35B 2.42B 2.42B 2.44B 2.54B
Eye Care Growth
-7.16% -9.88% -7.26% -7.60% -10.59% -21.20% -26.54% -27.92%

Revenue by Geography
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
US
43.03B 42.41B 42.11B 41.72B 41.88B 42.97B 43.88B 44.57B
US Growth
2.74% -1.30% -4.03% -6.38% -8.38% -4.94% -1.87% 0.96%
International
13.31B 13.13B 12.89B 12.68B 12.44B 12.17B 12.15B 12.18B
International Growth
7.00% 7.85% 6.12% 4.15% 0.76% -3.55% -3.86% -3.50%

Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Selling, General, and Administrative
14.75B 14.09B 13.26B 13.15B 12.87B 13.10B 13.03B 15.17B
Selling, General, and Administrative Growth
14.61% 7.59% 1.76% -13.34% -15.65% -13.29% -12.46% 20.09%
Research and Development
12.79B 7.94B 7.54B 7.32B 7.68B 7.54B 7.43B 7.31B
Research and Development Growth
66.66% 5.39% 1.45% 0.23% 17.90% 15.14% 12.66% 8.19%
Acquired In-Process R&D
2.76B 1.47B 1.45B 792.00M 778.00M 739.00M 713.00M 702.00M
Acquired In-Process R&D Growth
254.37% 98.24% 103.23% 12.82% 11.62% -13.97% -41.61% -35.24%
Other
-7.00M - - - - - 49.00M 46.00M
Other Growth
- - - - - - -85.06% -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.